HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $9 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Edward White has reiterated a 'Buy' rating on InflaRx (NASDAQ:IFRX), maintaining a price target of $9.
August 11, 2023 | 10:29 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
InflaRx's stock may see positive movement as HC Wainwright & Co. maintains a 'Buy' rating with a $9 price target.
Analyst ratings often influence the short-term movement of a stock. In this case, the 'Buy' rating from HC Wainwright & Co. indicates a positive outlook for InflaRx, which could lead to an increase in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100